Skip to main content

Table 3 Rescue analgesic administration

From: Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial

Postoperative time (h)

Group P (n = 47)

Group A (n = 46)

0−2

15

13

2−6

7

9

6−24

4

4

24−48

0

1

Total incidence

26

27

Total patients

17

20

  1. The data represent the number of patients. Group P was given 0.075 mg of palonosetron intravenously, whereas group A was given 40 mg of oral aprepitant. The total number of patients excludes the number of patients with repeated administration (5 patients in the palonosetron group and 4 patients in the aprepitant group). No significant differences were observed between groups P and A.